MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo. Fiedler LR, Chapman K, Xie M, Maifoshie E, et al. Cell Stem Cell 2020;26:458.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fiedler LR, Chapman K, Xie M, Maifoshie E, et al. MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo. Cell Stem Cell 2020;26:458.
PMID: 32142664